IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 114 filers reported holding IMMUNOVANT INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,082,477 | +76.1% | 1,252,474 | -13.0% | 12.15% | +46.6% |
| Q2 2023 | $27,308,150 | +22.3% | 1,439,544 | 0.0% | 8.29% | -4.4% |
| Q1 2023 | $22,327,327 | +83758.5% | 1,439,544 | -4.0% | 8.67% | -2.0% |
| Q4 2022 | $26,625 | -99.9% | 1,500,000 | -65.5% | 8.85% | +55.9% |
| Q3 2022 | $24,262,000 | +39.9% | 4,348,017 | -2.2% | 5.68% | +29.3% |
| Q2 2022 | $17,347,000 | -59.2% | 4,448,017 | -42.4% | 4.39% | -17.0% |
| Q1 2022 | $42,556,000 | +66.1% | 7,723,578 | +156.9% | 5.29% | +40.4% |
| Q4 2021 | $25,620,000 | -1.7% | 3,007,000 | +0.2% | 3.77% | -36.4% |
| Q3 2021 | $26,072,000 | +23.3% | 3,000,200 | +50.0% | 5.92% | +105.6% |
| Q2 2021 | $21,140,000 | +20.1% | 2,000,000 | +82.3% | 2.88% | +70.7% |
| Q1 2021 | $17,596,000 | – | 1,096,978 | – | 1.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |